Financial Snapshot

Revenue
$0.00
TTM
Gross Margin
Net Earnings
-$94.05M
TTM
Current Assets
Q2 2024
Current Liabilities
Q2 2024
Current Ratio
107.2%
Q2 2024
Total Assets
Q2 2024
Total Liabilities
Q2 2024
Book Value
-$83.67M
Q2 2024
Cash
Q2 2024
P/E
-0.4175
Nov 29, 2024 EST
Free Cash Flow

Revenues

Revenues

Loading...

Revenue YoY Change

Loading...

Revenues

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue $0.00 $0.00 $0.00 $0.00 $8.150M $3.090M $3.810M $2.980M $5.220M $9.050M
YoY Change -100.0% 163.75% -18.9% 27.85% -42.91% -42.32%

Expenses

Cost Of Revenues

Loading...

Gross Profit

Loading...

Gross Profit Margin

Loading...

Gross Profit

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue $0.00 $0.00 $0.00 $0.00 $8.150M $3.090M $3.810M $2.980M $5.220M $9.050M
Cost Of Revenue
Gross Profit
Gross Profit Margin

Selling, General & Admin Expense

Loading...

Research & Development

Loading...

Depreciation, Depletion & Amortization

Loading...

SGA Expense to Gross Profit Ratio

Loading...

R&D To Gross Profit Ratio

Loading...

DDA To Gross Profit Ratio

Loading...

Operating Expenses Total

Loading...

Operating Profits/Loss

Loading...

Operational Expenses

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Selling, General & Admin $26.67M $20.74M $12.77M $9.970M $9.370M $14.23M $15.88M $21.56M $12.91M $7.320M
YoY Change 28.61% 62.43% 28.07% 6.4% -34.15% -10.39% -26.35% 67.0% 76.37%
% of Gross Profit
Research & Development $26.45M $42.33M $38.96M $26.34M $23.81M $18.50M $23.81M $32.76M $38.88M $14.12M
YoY Change -37.51% 8.66% 47.89% 10.63% 28.7% -22.3% -27.32% -15.74% 175.35%
% of Gross Profit
Depreciation & Amortization $44.19K $163.6K $163.6K $219.4K $3.360M $3.050M $2.690M $2.390M $1.820M $880.0K
YoY Change -72.99% 0.0% -25.43% -93.47% 10.16% 13.38% 12.55% 31.32% 106.82%
% of Gross Profit
Operating Expenses $26.45M $42.33M $51.73M $36.84M $33.17M $32.73M $39.69M $54.33M $51.78M $21.44M
YoY Change -37.51% -18.16% 40.41% 11.07% 1.34% -17.54% -26.95% 4.92% 141.51%
Operating Profit -$53.13M -$63.07M -$51.73M -$36.84M
YoY Change -15.77% 21.93% 40.41%

Interest Expenses

Loading...

Interest Expenses To Operating Income %

Loading...

Other Expense/Income

Loading...

Interest & Other Expense/Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Interest Expense -$1.571M -$1.536M -$982.5K -$1.760M -$3.470M -$3.890M -$5.630M -$1.850M -$2.300M -$900.0K
YoY Change 2.26% 56.34% -44.18% -49.28% -10.8% -30.91% 204.32% -19.57% 155.56%
% of Operating Profit
Other Income/Expense, Net -$3.705M -$417.0K -$452.2K $1.980M $2.440M $1.050M $3.160M $0.00
YoY Change 788.51% -7.77% -122.84% -18.85% 132.38% -66.77%

Income/Loss

Pretax Income

Loading...

Income Tax

Loading...

Net Profits/Loss

Loading...

Pretax Income YoY Change

Loading...

Income Tax Rate

Loading...

Net Profits/Loss YoY Change

Loading...

Basic EPS

Loading...

Net Income To Revenue Ratio

Loading...

Pretax & Net Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Pretax Income -$58.98M -$66.05M -$53.16M -$38.51M -$37.93M -$33.74M -$38.35M -$53.20M -$48.86M -$13.29M
YoY Change -10.7% 24.24% 38.04% 1.53% 12.42% -12.02% -27.91% 8.88% 267.64%
Income Tax $2.800K $2.800K $2.000K -$3.272M -$3.410M -$3.650M $500.0K $100.0K -$190.0K $440.0K
% Of Pretax Income
Net Earnings -$58.98M -$66.05M -$53.16M -$35.24M -$34.52M -$30.09M -$38.85M -$53.30M -$47.39M -$13.73M
YoY Change -10.7% 24.24% 50.86% 2.08% 14.72% -22.55% -27.11% 12.47% 245.16%
Net Earnings / Revenue -423.56% -973.79% -1019.69% -1788.59% -907.85% -151.71%
Basic Earnings Per Share -$0.24 -$0.31 -$0.35 -$0.67
Diluted Earnings Per Share -$0.24 -$0.31 -$0.35 -$0.67 -$1.898M -$6.103M -$12.95M -$24.79M -$10.48M -$4.818M

Assets & Liabilities

Cash & Short-Term Investments

Loading...

Cash & Equivalents

Loading...

Cash To Operating Expenses Ratio

Loading...

Inventory

Loading...

Receivables

Loading...

Total Short-Term Assets

Loading...

Property, Plant And Equipment

Loading...

Long-Term Investments

Loading...

Total Long-Term Assets

Loading...

Total Assets

Loading...

Net Income To Total Assets Percentage

Loading...

Accounts Payable

Loading...

Short-Term Debt

Loading...

Long Term Debt Due

Loading...

Total Short-Term Liabilities

Loading...

Long-Term Debt

Loading...

Other Long-Term Liabilities

Loading...

Total Long-Term Liabilities

Loading...

Total Liabilities

Loading...

Short-Term To Long-Term Debt Ratio

Loading...

Short-Term Assets To Debt Ratio

Loading...

Long-Term Debt To Net Income Ratio

Loading...

Assets & Liabilities

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Cash & Short-Term Investments $23.39M $17.40M $14.48M $12.54M $8.020M $1.720M $3.190M $2.350M $9.070M $2.350M
YoY Change 34.46% 20.17% 15.45% 56.36% 366.28% -46.08% 35.74% -74.09% 285.96%
Cash & Equivalents $23.39M
Short-Term Investments
Other Short-Term Assets $7.587M $10.12M $7.031M $5.410M $5.490M $1.590M $720.0K $3.330M $1.790M $800.0K
YoY Change -25.05% 43.99% 29.96% -1.46% 245.28% 120.83% -78.38% 86.03% 123.75%
Inventory
Prepaid Expenses
Receivables $20.00K $0.00
Other Receivables $4.280M $0.00
Total Short-Term Assets $30.98M $27.52M $21.51M $17.94M $13.50M $3.300M $3.900M $5.680M $15.16M $3.150M
YoY Change 12.57% 27.95% 19.89% 32.89% 309.09% -15.38% -31.34% -62.53% 381.27%
Property, Plant & Equipment $26.17K $70.36K $275.1K $490.0K $3.180M $18.49M $16.09M $18.66M $17.76M $8.010M
YoY Change -62.81% -74.42% -43.87% -84.59% -82.8% 14.92% -13.77% 5.07% 121.72%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $793.9K $804.9K $853.7K $900.0K
YoY Change -1.37% -5.71% -5.15%
Other Assets $501.3K $132.0K $174.6K $390.0K $460.0K $490.0K $740.0K $1.070M $2.080M $450.0K
YoY Change 279.72% -24.38% -55.23% -15.22% -6.12% -33.78% -30.84% -48.56% 362.22%
Total Long-Term Assets $1.321M $1.007M $1.303M $1.790M $3.640M $18.98M $16.83M $19.73M $19.85M $8.450M
YoY Change 31.18% -22.71% -27.19% -50.82% -80.82% 12.77% -14.7% -0.6% 134.91%
Total Assets $32.30M $28.53M $22.81M $19.73M $17.14M $22.28M $20.73M $25.41M $35.01M $11.60M
YoY Change
Accounts Payable $6.575M $3.491M $2.196M $2.390M $2.280M $3.610M $10.95M $5.070M $11.56M $3.100M
YoY Change 88.3% 58.97% -8.1% 4.82% -36.84% -67.03% 115.98% -56.14% 272.9%
Accrued Expenses $2.746M $3.455M $1.769M $7.940M $4.620M $6.460M $7.340M $6.120M $5.920M $2.560M
YoY Change -20.53% 95.35% -77.73% 71.86% -28.48% -11.99% 19.93% 3.38% 131.25%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00 $0.00 $6.700M $13.18M $0.00 $0.00 $0.00 $0.00
YoY Change -100.0% -49.17%
Long-Term Debt Due $35.56M $10.93M $930.7K $3.690M $4.830M $5.200M $5.010M $6.180M $15.82M $11.48M
YoY Change 225.4% 1074.09% -74.78% -23.6% -7.12% 3.79% -18.93% -60.94% 37.8%
Total Short-Term Liabilities $46.73M $19.73M $6.752M $15.89M $20.29M $32.04M $28.74M $20.44M $37.04M $20.21M
YoY Change 136.86% 192.2% -57.51% -21.69% -36.67% 11.48% 40.61% -44.82% 83.28%
Long-Term Debt $0.00 $4.270K $10.90M $950.0K $3.420M $3.550M $13.41M $2.550M $6.140M $3.690M
YoY Change -100.0% -99.96% 1047.57% -72.22% -3.66% -73.53% 425.88% -58.47% 66.4%
Other Long-Term Liabilities $6.220K $57.14K $549.9K $70.00K $4.200M $7.500M $9.310M $7.590M $19.38M $8.150M
YoY Change -89.11% -89.61% 685.59% -98.33% -44.0% -19.44% 22.66% -60.84% 137.79%
Total Long-Term Liabilities $6.220K $61.41K $11.45M $1.020M $7.620M $11.05M $22.72M $10.14M $25.52M $11.84M
YoY Change -89.87% -99.46% 1022.72% -86.61% -31.04% -51.36% 124.06% -60.27% 115.54%
Total Liabilities $46.74M $19.79M $18.20M $16.91M $27.90M $43.09M $51.46M $30.58M $63.61M $35.15M
YoY Change 136.16% 8.72% 7.65% -39.39% -35.25% -16.27% 68.28% -51.93% 80.97%

Ownership

Basic Shares Outstanding

Loading...

Diluted Shares Outstanding

Loading...

Preferred Stock

Loading...

Treasury Stock Shares

Loading...

Stock Issuance & Repurchase

Loading...

Ownership Data

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Basic Shares Outstanding 250.2M 212.1M 152.7M 72.56M
Diluted Shares Outstanding 250.2M 212.1M 152.7M 72.56M
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Loading...

Book Value

Loading...

Free Cash Flow

Loading...

Free Cash Flow YoY

Loading...

Free Cash Flow Margin

Loading...

Dividends

Dividends

Loading...

Stock Price

Loading...
Market Cap: $39.268 Million

About Outlook Therapeutics, Inc.

Outlook Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of ONS-5010/LYTENAVA. The company is headquartered in Iselin, New Jersey and currently employs 24 full-time employees. The company went IPO on 2016-06-13. The firm focuses on developing and commercializing ONS-5010 (LYTENAVA (bevacizumab-vikg)), an ophthalmic formulation of bevacizumab for use in retinal indications. The firm's product candidate, ONS-5010, is developed to be administered as an intravitreal injection for the treatment of wet age-related macular degeneration (wet AMD), diabetic macular edema (DME), and branch retinal vein occlusion (BRVO). Bevacizumab is a full-length, humanized anti-Vascular Endothelial Growth Factor (VEGF) recombinant monoclonal antibody (mAb), that inhibits VEGF and associated angiogenic activity. VEGF is a protein that promotes the growth of new abnormal blood vessels. Its biologics license application (BLA) for ONS-5010 in wet AMD involved three clinical trials, which include NORSE ONE, NORSE TWO and NORSE THREE. The firm sells ONS-5010 in the United States, United Kingdom, Europe, Japan and other markets.

Industry: Biological Products, (No Diagnostic Substances) Peers: 4D Molecular Therapeutics, Inc. Aadi Bioscience, Inc. AVEO PHARMACEUTICALS, INC. Vaxart, Inc. Generation Bio Co. Poseida Therapeutics, Inc. Summit Therapeutics Inc. Vaxxinity, Inc.